# Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation

Study · id `cardio:ct-nct02325830` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02325830](<https://clinicaltrials.gov/study/NCT02325830>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02325830

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.

## Technical summary

Registry record NCT02325830. Randomized; double masking; primary purpose treatment. Start 2015-08-22 (actual); primary completion 2018-07-01 (actual). Results posted on 2024-08-05.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 163 participants (enrolled count; ClinicalTrials.gov record NCT02325830, source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)
- Started: 2015-08-22 (actual) (ClinicalTrials.gov record NCT02325830, source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)
- Primary completion: 2018-07-01 (actual) (ClinicalTrials.gov record NCT02325830, source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)
- Completion: 2020-01-08 (actual) (ClinicalTrials.gov record NCT02325830, source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)
- Results first posted: 2024-08-05 (ClinicalTrials.gov record NCT02325830, source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)
- Countries: Australia; Czechia; France; Germany; Netherlands; New Zealand; Poland; United Kingdom (ClinicalTrials.gov record NCT02325830, source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02325830-2024-08-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
- Acronym: REDUCE FMR
- Condition: Mitral Valve Insufficiency
- Condition: Heart Failure
- Intervention (Device): Carillon Mitral Contour System
- Lead sponsor: Cardiac Dimensions Pty Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Menzies Institute for Medical Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation (`cardio:pubmed-31521683`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0b6962ea1789558a601eb38edf7ff5877b199825eef8ad68ff6db098691a684e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
